Hypoxia-mediated SUMOylation of FADD exacerbates endothelial cell injury via the RIPK1-RIPK3-MLKL signaling axis
Authors:
Open Access
- 21 February 2025
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-13
Abstract
Vascular endothelial cells are the predominant cell type in the cardiovascular system, and their dysfunction and death following hypoxic injury contribute to vascular lesions, playing an essential role in cardiovascular disease. Despite its importance, the mechanisms underlying vascular endothelial cell injury under hypoxia and potential therapeutic interventions remain poorly understood. Here, we constructed both an in vivo hypoxia model in C57BL/6 mice and an in vitro hypoxia model in HUVEC cells. Our findings demonstrated that hypoxia induces necroptosis in vascular endothelial cells and exacerbates inflammatory injury in vivo and in vitro, as evidenced by immunofluorescence and western blot. We identified FADD as a critical regulator of hypoxia-mediated necroptosis, with FADD knockdown significantly reversing hypoxia-induced necroptosis. Mechanistically, hypoxia affected protein conformation through SUMOylation of FADD and competitively inhibited its ubiquitination, leading to an increase in protein half-life and protein level of FADD. Furthermore, SUMOylation increased the interaction between FADD and RIPK1 and induced the formation of the FADD-RIPK1-RIPK3 complex, thereby promoting necroptosis in vascular endothelial cells. The SUMOylation inhibitor ginkgolic acid (GA) notably reduced hypoxia-induced vascular endothelial injury and inflammatory responses in male mice. Taken together, our research has uncovered a new process by which SUMOylation of FADD regulates hypoxia-induced necroptosis in endothelial cells, providing potential therapeutic targets for hypoxia-related cardiovascular diseases.Keywords
All Related Versions
This publication has 46 references indexed in Scilit:
- The SUMOylation and ubiquitination crosstalk in cancerJournal of Cancer Research and Clinical Oncology, 2023
- Hypoxia modeling techniques: A reviewHeliyon, 2023
- CCL2-targeted ginkgolic acid exerts anti-glioblastoma effects by inhibiting the JAK3-STAT1/PI3K-AKT signaling pathwayLife Sciences, 2022
- A Tale of Two: When Neural Stem Cells Encounter HypoxiaCellular and Molecular Neurobiology, 2022
- Ginkgo biloba Extracts: A Review of the Pharmacokinetics of the Active IngredientsClinical Pharmacokinetics, 2013
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 KinaseCell, 2012
- Hypoxia-Inducible Factors and the Response to Hypoxic StressMolecular Cell, 2010
- FADD: a regulator of life and deathTrends in Immunology, 2010
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced InflammationCell, 2009
- SUMO-Specific Protease 1 Is Essential for Stabilization of HIF1α during HypoxiaCell, 2007